According to the results of a new study, using Takeda’s controversial diabetes drug Actos (generic: pioglitazone) may significantly increase the risk of developing a severe eye problem known as macular edema. This condition causes the macula region of the eye to swell, leading to a loss of visual acuity. Signs and symptoms of Actos-induced macular edema may include blurred or wavy central vision and/or colors that appear ‘washed out’ or changed.
Actos Bladder Cancer Lawsuit Update 6/14/12: If Takeda Pharmaceuticals’ attorneys have their way, patients diagnosed with bladder cancer after using Actos will face a deadline for filing their lawsuit tomorrow, if the drug was prescribed or taken in a state with a one-year statute of limitations. June 15, 2012, marks exactly one year after the U.S. Food & Drug Administration (FDA) issued a warning about the possible link between Actos and bladder cancer. Click here to learn more.
Free Actos Lawsuit Evaluation: If you or a loved one has been injured by Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Actos and we can help.
What’s the problem?
June 13, 2012 – In a study published this week in the Archives of Internal Medicine, researchers found that prescription drugs from the thiazolidinedione class – which include Actos and Avandia – may double or even triple the risk of developing macular edema, a condition that could lead to blindness.
The study examined data on 103,368 type-II diabetics, and found that patients who took Actos or Avandia had a 1.3% chance of developing macular edema, compared to just 0.2% among individuals who took no such thiazolidinedione drugs. The results of the study indicated the risk was the same whether the patient was taking Actos or Avandia.
The research, which was first introduced last summer at a meeting of the American Diabetes Association in San Diego, CA., has now been peer-reviewed and published.
Due to the fact that thiazolidinediones are considered second-line treatment options for individuals who have problems controlling their diabetes, the study was unable to conclusively determine whether Actos or Avandia actually have the potential to cause macular edema. However, the research raises additional concerns about the controversial class of diabetes medications.
Manufactured and marketed by GlaxoSmithKline (GSK), Avandia (generic: rosiglitazone) was first approved in 1998 as a treatment for type-II diabetes. The drug enjoyed widespread success before sales began to plummet in mid-2007 after a study published in the New England Journal of Medicine identified a potential risk of heart attacks from Avandia.
Although many critics argued that Avandia should be recalled nationwide in response to the heart attack risk, the FDA allowed the drug to remain on the market under tight restrictions, available only through select pharmacies to patients who are already being successfully treated with the drug.
As sales for Avandia fell, diabetics began being prescribed Actos in unprecedented numbers. However, it wasn’t long before Actos was linked to an increased risk for bladder cancer, prompting calls for its own nationwide recall.
A growing number of Actos bladder cancer lawsuits are being filed against Takeda in courthouses around the country, alleging that the company was negligent in failing to properly research the drug or warn about the risk of bladder cancer.
Do I Have an Actos Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Actos lawsuits. We are handling individual litigation nationwide and currently accepting new side effects cases in all 50 states.
Free Actos Lawsuit Evaluation: If you or a loved one has been injured by Actos, you should contact our law firm immediately. You may be entitled to compensation by filing an Actos injury suit and we can help.